COBRE: UNV MED SCH: P1: INTEGRIN REGULATION OF VASCULAR SMOOTH MUSCLE
COBRE:UNV MED SCH:P1:血管平滑肌的整合素调节
基本信息
- 批准号:7960564
- 负责人:
- 金额:$ 19.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:Blood VesselsCardiopulmonaryCell Differentiation processCell-Matrix JunctionCellsCenters of Research ExcellenceCessation of lifeComplexComputer Retrieval of Information on Scientific Projects DatabaseDiseaseDuchenne muscular dystrophyDystrophinExhibitsFailureFundingGene MutationGlycoproteinsGrantHemorrhageHomeostasisITGA7 geneInstitutionIntegrinsLamininLightLongevityMediatingModelingMolecularMusMuscle CellsMuscle WeaknessOperative Surgical ProceduresPathologyPatientsPlayRegulationResearchResearch PersonnelResourcesRoleSkeletal MuscleSmooth MuscleSmooth Muscle MyocytesSourceTestingTransgenic OrganismsUnited States National Institutes of HealthVascular DiseasesVascular Smooth Musclebasehuman diseasemdx mouseresponse
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This proposal seeks to understand the functional roles of the alpha7beta1 integrin in regulating vascular smooth muscle plasticity and in vascular disease. The alpha7beta1 integrin and the dystrophin glycoprotein complex connect muscle cells to their surrounding matrix. Duchenne Muscular Dystrophy (DMD) patients and mdx mice (a model for the human disease) have genetic mutations that result in an absence of dystrophin. DMD is characterized by progressive muscle weakness leading to early death from cardiopulmonary failure. DMD
patients exhibit vascular abnormalities caused by weak smooth muscle cell attachment, poor contractile responses and excessive bleeding after surgery. In skeletal muscle of DMD patients and mdx mice, the alpha7beta1integrin is increased and may partially compensate for the absence of the dystrophin complex. Enhanced transgenic expression of the alpha7beta1 integrin in skeletal muscle increases the longevity and decreases the pathology of severely dystrophic mice, supporting the hypothesis that alpha7beta1 and the dystrophin complex functionally overlap. Both dystrophin and the alpha7beta1 integrin are expressed in vascular smooth muscle where they mediate cell attachment to laminin. The dystrophin complex is involved in vascular smooth muscle plasticity and Ca2+ homeostasis. This proposal will test the hypothesis that the alpha7beta1 integrin has a complementary role in regulating vascular smooth muscle cell plasticity. We will use mdx mice to determine if alpha7beta1 levels are increased in vascular smooth muscle in the absence of dystrophin. We will further determine if altered levels of the alpha7beta1 integrin result in alterations of Ca2+ homeostasis, cell contractility, vascular tone, and cell differentiation. Molecules downstream of the integrin will be analyzed to determine the mechanisms by which increased alpha7beta1 compensates for the absence of dystrophin. The alpha7beta1 integrin may play a critical role in vascular plasticity and disease and these studies may shed light on the underlying molecular basis of vascular function.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
该提案旨在了解 α7β1 整合素在调节血管平滑肌可塑性和血管疾病中的功能作用。 α7β1 整合素和肌营养不良蛋白糖蛋白复合物将肌肉细胞与其周围基质连接起来。杜氏肌营养不良症 (DMD) 患者和 mdx 小鼠(人类疾病模型)存在基因突变,导致肌营养不良蛋白缺失。 DMD 的特点是进行性肌肉无力,导致心肺衰竭过早死亡。 DMD
患者表现出因平滑肌细胞附着力薄弱、收缩反应差和手术后出血过多而引起的血管异常。在 DMD 患者和 mdx 小鼠的骨骼肌中,α7β1 整合素增加,可能部分补偿肌营养不良蛋白复合物的缺失。骨骼肌中α7β1整合素转基因表达的增强可延长严重营养不良小鼠的寿命并减少其病理状况,支持α7β1和肌营养不良蛋白复合物功能重叠的假设。肌营养不良蛋白和 α7β1 整合素均在血管平滑肌中表达,它们介导细胞与层粘连蛋白的附着。肌营养不良蛋白复合物参与血管平滑肌可塑性和 Ca2+ 稳态。该提案将检验α7β1整合素在调节血管平滑肌细胞可塑性方面具有补充作用的假设。我们将使用 mdx 小鼠来确定在缺乏肌营养不良蛋白的情况下血管平滑肌中的 alpha7beta1 水平是否增加。我们将进一步确定 α7β1 整合素水平的改变是否会导致 Ca2+ 稳态、细胞收缩性、血管张力和细胞分化的改变。将分析整合素下游的分子,以确定增加的 α7β1 补偿肌营养不良蛋白缺失的机制。 α7β1 整合素可能在血管可塑性和疾病中发挥关键作用,这些研究可能揭示血管功能的分子基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEAN J. BURKIN其他文献
DEAN J. BURKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEAN J. BURKIN', 18)}}的其他基金
Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy
用于治疗杜氏肌营养不良症的整合素增强分子的优化
- 批准号:
10010445 - 财政年份:2015
- 资助金额:
$ 19.32万 - 项目类别:
Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy
用于治疗杜氏肌营养不良症的整合素增强分子的优化
- 批准号:
10246962 - 财政年份:2015
- 资助金额:
$ 19.32万 - 项目类别:
Laminin protein therapy for Congenital Muscular Dystrophy
层粘连蛋白治疗先天性肌营养不良症
- 批准号:
8697998 - 财政年份:2014
- 资助金额:
$ 19.32万 - 项目类别:
Galectin 1: A novel small protein therapy for Duchenne muscular dystrophy
半乳糖凝集素 1:一种治疗杜氏肌营养不良症的新型小蛋白疗法
- 批准号:
9104670 - 财政年份:2014
- 资助金额:
$ 19.32万 - 项目类别:
Galectin 1: A novel small protein therapy for Duchenne muscular dystrophy
半乳糖凝集素 1:一种治疗杜氏肌营养不良症的新型小蛋白疗法
- 批准号:
8781546 - 财政年份:2014
- 资助金额:
$ 19.32万 - 项目类别:
Laminin protein therapy for Congenital Muscular Dystrophy
层粘连蛋白治疗先天性肌营养不良症
- 批准号:
8877405 - 财政年份:2014
- 资助金额:
$ 19.32万 - 项目类别:
Congenital Muscular Dystrophy: From Clinical Pathology to Underlying Scientific M
先天性肌营养不良症:从临床病理学到基础科学 M
- 批准号:
8319246 - 财政年份:2012
- 资助金额:
$ 19.32万 - 项目类别:
Preclinical Testing of Integrin Enhancing Molecules for the Treatment of Muscular
整合素增强分子治疗肌肉萎缩症的临床前测试
- 批准号:
8131058 - 财政年份:2010
- 资助金额:
$ 19.32万 - 项目类别:
Preclinical Testing of Integrin Enhancing Molecules for the Treatment of Muscular
整合素增强分子治疗肌肉萎缩症的临床前测试
- 批准号:
7970910 - 财政年份:2010
- 资助金额:
$ 19.32万 - 项目类别:
COBRE: UNR: TARGETED & TRANSGENIC ANIMAL CORE (A): ES CELLS
COBRE:UNR:有针对性
- 批准号:
7959484 - 财政年份:2009
- 资助金额:
$ 19.32万 - 项目类别:
相似海外基金
Explainable Pattern Recognition of Cardiopulmonary Coupling and its Application to Personal Sleep Monitoring
心肺耦合的可解释模式识别及其在个人睡眠监测中的应用
- 批准号:
23K11305 - 财政年份:2023
- 资助金额:
$ 19.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study of the Effect of Changes in Blood Flow to the Brain Before and After Cardiopulmonary Bypass on Postoperative Delirium
体外循环前后脑血流变化对术后谵妄的影响研究
- 批准号:
23K08418 - 财政年份:2023
- 资助金额:
$ 19.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research and development of a virtual cardiopulmonary bypass/ECMO simulator using MR (Mixed Reality)
利用MR(混合现实)研发虚拟体外循环/ECMO模拟器
- 批准号:
23K15535 - 财政年份:2023
- 资助金额:
$ 19.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Improving Community-level Bystander Cardiopulmonary Resuscitation in Underserved Populations
改善服务不足人群的社区级旁观者心肺复苏
- 批准号:
10738902 - 财政年份:2023
- 资助金额:
$ 19.32万 - 项目类别:
Trajectories of Regional Cardiopulmonary Structure and Function in A Longitudinal Cohort of Extremely Preterm Infants
极早产儿纵向队列的区域心肺结构和功能轨迹
- 批准号:
10656624 - 财政年份:2023
- 资助金额:
$ 19.32万 - 项目类别:
Novel cardiopulmonary exercise testing variables to differentiate neuromuscular deconditioning from disease
新型心肺运动测试变量可区分神经肌肉功能失调与疾病
- 批准号:
10736044 - 财政年份:2023
- 资助金额:
$ 19.32万 - 项目类别:
Cardiopulmonary outcomes of dual cigarette and e-cigarette use in animal models of chronic exposure
慢性暴露动物模型中同时使用香烟和电子烟的心肺结果
- 批准号:
10666054 - 财政年份:2023
- 资助金额:
$ 19.32万 - 项目类别:
Plastic Chemicals in Pediatric Cardiopulmonary Bypass: Evaluating Cardiac Toxicity and Investigating Clinical Alternatives
儿科心肺绕道中的塑料化学品:评估心脏毒性并研究临床替代方案
- 批准号:
10677964 - 财政年份:2023
- 资助金额:
$ 19.32万 - 项目类别:
Mindful Steps: A Web-Based Mind-Body Exercise Intervention to Promote Physical Activity in Chronic Cardiopulmonary Disease
正念步骤:基于网络的身心运动干预,促进慢性心肺疾病的体力活动
- 批准号:
10732824 - 财政年份:2023
- 资助金额:
$ 19.32万 - 项目类别:
Research regarding the elucidation of cell death caused by cardiopulmonary arrest and resuscitation intending to establish the new cardiopulmonary resuscitation
阐明心肺骤停和复苏引起的细胞死亡的研究,旨在建立新的心肺复苏
- 批准号:
23K08439 - 财政年份:2023
- 资助金额:
$ 19.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)